|
1
|
Claes A, Idema AJ and Wesseling P: Diffuse
glioma growth: A guerilla war. Acta Neuropathol. 114:443–458. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY, Fine HA, Black PM, Shrieve DC,
Alexander E III and Loeffler JS: High-grade astrocytomas. Neurol
Clin. 13:875–900. 1995.PubMed/NCBI
|
|
3
|
Kleihues P, Soylemezoglu F, Schäuble B,
Scheithauer BW and Burger PC: Histopathology, classification, and
grading of gliomas. Glia. 15:211–221. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ostrom QT, Gittleman H, Farah P, et al:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol.
15(Suppl 2): ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bao S, Wu Q, Li Z, Sathornsumetee S, Wang
H, McLendon RE, Hjelmeland AB and Rich JN: Targeting cancer stem
cells through L1CAM suppresses glioma growth. Cancer Res.
68:6043–6048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan X, Curtin J, Xiong Y, Liu G, Hogiu S
Waschsmann, Farkas DL, Black KL and Yu JS: Isolation of cancer stem
cells from adult glioblastoma multiforme. Oncogene. 23:9392–9400.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holland EC: Glioblastoma multiforme: The
terminator. Proc Natl Acad Sci USA. 97:6242–6244. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boyd JM, Subramanian T, Schaeper U, La
Regina M, Bayley S and Chinnadurai G: A region in the C-terminus of
adenovirus 2/5 E1a protein is required for association with a
cellular phosphoprotein and important for the negative modulation
of T24-ras mediated transformation, tumorigenesis and metastasis.
EMBO J. 12:469–478. 1993.PubMed/NCBI
|
|
10
|
Bergman LM and Blaydes JP: C-terminal
binding proteins: Emerging roles in cell survival and
tumorigenesis. Apoptosis. 11:879–888. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chinnadurai G: The transcriptional
corepressor CtBP: A foe of multiple tumor suppressors. Cancer Res.
69:731–734. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Corda D, Colanzi A and Luini A: The
multiple activities of CtBP/BARS proteins: The Golgi view. Trends
Cell Biol. 16:167–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meloni AR, Smith EJ and Nevins JR: A
mechanism for Rb/p130-mediated transcription repression involving
recruitment of the CtBP corepressor. Proc Natl Acad Sci USA.
96:9574–9579. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Izutsu K, Kurokawa M, Imai Y, Maki K,
Mitani K and Hirai H: The corepressor CtBP interacts with Evi-1 to
repress transforming growth factor beta signaling. Blood.
97:2815–2822. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hamada F and Bienz M: The APC tumor
suppressor binds to C-terminal binding protein to divert nuclear
beta-catenin from TCF. Dev Cell. 7:677–685. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Van Hateren N, Shenton T and Borycki AG:
Expression of avian C-terminal binding proteins (Ctbp1 and Ctbp2)
during embryonic development. Dev Dyn. 235:490–495. 2006.
View Article : Google Scholar
|
|
17
|
Hildebrand JD and Soriano P: Overlapping
and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2
during mouse development. Mol Cell Biol. 22:5296–5307. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chinnadurai G: CtBP, an unconventional
transcriptional corepressor in development and oncogenesis. Mol
Cell. 9:213–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paliwal S, Kovi RC, Nath B, Chen YW, Lewis
BC and Grossman SR: The alternative reading frame tumor suppressor
antagonizes hypoxia-induced cancer cell migration via interaction
with the COOH-terminal binding protein corepressor. Cancer Res.
67:9322–9329. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mor V, Laliberte L, Morris JN and Wiemann
M: The Karnofsky Performance Status Scale. An examination of its
reliability and validity in a research setting. Cancer.
53:2002–2007. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fuller GN and Scheithauer BW: The 2007
Revised World Health Organization (WHO) Classification of Tumours
of the Central Nervous System: Newly codified entities. Brain
Pathol. 17:304–307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu R, Liu X, Zheng Y, Gu J, Xiong S,
Jiang P, Jiang X, Huang E, Yang Y, Ge D and Chu Y: MicroRNA-7
sensitizes non-small cell lung cancer cells to paclitaxel. Oncol
Lett. 8:2193–2200. 2014.PubMed/NCBI
|
|
23
|
Soffietti R, Bertero L, Pinessi L and Rudà
R: Pharmacologic therapies for malignant glioma: A guide for
clinicians. CNS Drugs. 28:1127–1137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu CX, Lin GS, Lin ZX, Zhang JD, Chen L,
Liu SY, Tang WL, Qiu XX and Zhou CF: Peritumoral edema on magnetic
resonance imaging predicts a poor clinical outcome in malignant
glioma. Oncology letters. 10:2769–2776. 2015.PubMed/NCBI
|
|
25
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth after chemotherapy. Nature. 488:522–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kovi RC, Paliwal S, Pande S and Grossman
SR: An ARF/CtBP2 complex regulates BH3-only gene expression and
p53-independent apoptosis. Cell Death Differ. 17:513–521. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mirnezami AH, Campbell SJ, Darley M,
Primrose JN, Johnson PW and Blaydes JP: Hdm2 recruits a
hypoxia-sensitive corepressor to negatively regulate p53-dependent
transcription. Curr Biol. 13:1234–1239. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan CB, Liu X, Jang SW, Hsu SI, Williams
I, Kang S, Chen J and Ye K: NGF inhibits human leukemia
proliferation by downregulating cyclin A1 expression through
promoting acinus/CtBP2 association. Oncogene. 28:3825–3836. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hübler D, Rankovic M, Richter K, Lazarevic
V, Altrock WD, Fischer KD, Gundelfinger ED and Fejtova A:
Differential spatial expression and subcellular localization of
CtBP family members in rodent brain. PLoS One. 7:e397102012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Birts CN, Harding R, Soosaipillai G,
Halder T, Azim-Araghi A, Darley M, Cutress RI, Bateman AC and
Blaydes JP: Expression of CtBP family protein isoforms in breast
cancer and their role in chemoresistance. Biol Cell. 103:1–19.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paliwal S, Pande S, Kovi RC, Sharpless NE,
Bardeesy N and Grossman SR: Targeting of C-terminal binding protein
(CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol.
26:2360–2372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muniz VP, Barnes JM, Paliwal S, Zhang X,
Tang X, Chen S, Zamba KD, Cullen JJ, Meyerholz DK, Meyers S, et al:
The ARF tumor suppressor inhibits tumor cell colonization
independent of p53 in a novel mouse model of pancreatic ductal
adenocarcinoma metastasis. Mol Cancer Res. 9:867–877. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guan C, Shi H, Wang H, Zhang J, Ni W, Chen
B, Hou S, Yang X, Shen A and Ni R: CtBP2 contributes to malignant
development of human esophageal squamous cell carcinoma by
regulation of p16INK4A. J Cell Biochem. 114:1343–1354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
